Pfizer downgraded to Hold from Buy at HSBC
bearish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bearish
What happened, with direct paths to the underlying reporting
HSBC downgrades Pfizer to Hold from Buy; target remains $28; price around $24.32.
Target: $28
Posted price: $24.32
Analyst firm: HSBC
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.